16% off (Sale price $480.12, Reg. Price $573.99) :: DRAXXIN tulathromycin, is the first entry of a novel macrolide subclass, the triamilides, developed by Pfizer Animal Health. DRAXXIN is now the first-line product-of-choice to treat BRD, offering both superior disease treatment as well as outstanding efficacy for the control of BRD in cattle at high risk of developing the disease.
|